secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2025-01-08T23:59:59+00:00
Accession:  0001493152-25-001401
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals raises $900k via Series B Preferred and warrants for 1.188M shares
--------------------------------------------------------------------------------

- Closed four SPAs from Dec 31, 2024 through Jan 6, 2025, selling 900 shares of Series B Preferred at $1,000 each for $900k total.
- Issued warrants to purchase up to 1,188,000 shares, exercisable at 105% of 10-day VWAP (range $2.57–$2.61), 5-year term.
- Warrants exercisable after 180 days; include dilutive issuance price adjustments and cashless exercise if registration not effective.
- Series B Preferred convertible at $1,100 stated value, floor price $2.25; 440,000 common shares issuable on full conversion.
- Offering of 1,250 Series B Preferred shares closed; securities issued under Section 4(a)(2)/Reg D, no public offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315225001401/0001493152-25-001401-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315225001401/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-001401

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer